Filing Details
- Accession Number:
- 0001326110-23-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-05 21:52:51
- Reporting Period:
- 2023-06-05
- Accepted Time:
- 2023-06-05 21:52:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326110 | Immunitybio Inc. | IBRX | Biological Products, (No Disgnostic Substances) (2836) | 431979754 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1371407 | D Michael Blaszyk | C/O Immunitybio, Inc. 3530 John Hopkins Court San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-05 | 23,430 | $2.72 | 23,430 | No | 4 | P | Indirect | By trust |
Common Stock | Acquisiton | 2023-06-05 | 48,000 | $2.77 | 71,430 | No | 4 | P | Indirect | By trust |
Common Stock | Acquisiton | 2023-06-05 | 485 | $2.75 | 71,915 | No | 4 | P | Indirect | By trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By trust |
No | 4 | P | Indirect | By trust |
No | 4 | P | Indirect | By trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 193,667 | Direct |